Co-administration of DMH and non-steroidal anti-inflammatory drugs (NSAIDs) such as the CRC-preventing sulindac and celecoxib leads to significant decreases in NHE1 expression implying that NHE1 contributes to colonic tumor progression (Vaish and Sanyal, 2012). This evidence concerns the gene SLC9A1 and colonic neoplasm.